AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six research firms ...

Representatives from Breakthrough T1D, a leading global organization funding Type 1 diabetes research, visited Rice to learn ...

Victory Capital Management Inc. lifted its position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 727.4% in the 3rd ...

Nov 7(Reuters) - Insulet (PODD.O), opens new tab raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker ...

Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...

Help a Diabetic Child is a Naples non-profit focused on helping families facing diabetes. Insulin pumps cost roughly $50 and ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

Insulin Pumps and Insulin Jet Injectors. Insulin market has witnessed many firsts in the year 2019. This includes advent of first glucagon-like peptide (GLP-1) Rybelsus oral tablets. Secondly, FDA has ...

The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...

Embecta expects between $25 million and $30 million in pre-tax, cash charges for planned workforce reductions and other associated costs. Embecta expects between $35 million and $45 million in pre ...